Strs Ohio Bristol Myers Squibb CO Transaction History

Strs Ohio

$24.9 Billion
Q2 2024

A detailed history of Strs Ohio transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Strs Ohio holds 858,683 shares of BMY stock, worth $44.4 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

858,683

Previous 584,457 46.92%

Holding current value

$44.4 Million

Previous $31.7 Million 12.51%

% of portfolio

0.14%

Previous 0.13%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$40.25 - $52.99 $11 Million - $14.5 Million	274,226 Added 46.92%	858,683 $35.7 Million
Q1 2024 May 13, 2024	SELL	$47.98 - $54.4 $3.09 Million - $3.5 Million	-64,335 Reduced 9.92%	584,457 $31.7 Million
Q4 2023 Jan 30, 2024	SELL	$48.48 - $57.85 $1.99 Million - $2.38 Million	-41,079 Reduced 5.95%	648,792 $33.3 Million
Q3 2023 Oct 26, 2023	SELL	$57.89 - $64.73 $2.88 Million - $3.22 Million	-49,769 Reduced 6.73%	689,871 $40 Million
Q2 2023 Jul 31, 2023	SELL	$63.71 - $70.74 $3 Million - $3.34 Million	-47,153 Reduced 5.99%	739,640 $47.3 Million
Q1 2023 Aug 02, 2023	BUY	$65.71 - $74.53 $3.1 Million - $3.51 Million	47,153 Added 6.38%	786,793 $54.5 Million
Q1 2023 Apr 27, 2023	SELL	$65.71 - $74.53 $2.22 Million - $2.51 Million	-33,720 Reduced 4.11%	786,793 $54.5 Million
Q4 2022 Jan 26, 2023	SELL	$68.48 - $81.09 $1.41 Million - $1.67 Million	-20,559 Reduced 2.44%	820,513 $59 Million
Q3 2022 Oct 27, 2022	SELL	$0.13 - $76.84 $42,076 - $24.9 Million	-323,666 Reduced 27.79%	841,072 $59.8 Million
Q2 2022 Jul 25, 2022	BUY	$72.62 - $79.98 $1.75 Million - $1.93 Million	24,159 Added 2.12%	1,164,738 $89.7 Million
Q1 2022 Apr 21, 2022	BUY	$61.48 - $73.72 $25.8 Million - $30.9 Million	419,547 Added 58.19%	1,140,579 $83.3 Million
Q4 2021 Jan 24, 2022	SELL	$53.63 - $62.52 $3.03 Million - $3.53 Million	-56,416 Reduced 7.26%	721,032 $45 Million
Q3 2021 Oct 22, 2021	SELL	$59.17 - $69.31 $4.71 Million - $5.52 Million	-79,593 Reduced 9.29%	777,448 $46 Million
Q2 2021 Jul 26, 2021	SELL	$61.91 - $67.42 $4.34 Million - $4.72 Million	-70,032 Reduced 7.55%	857,041 $57.3 Million
Q1 2021 Apr 23, 2021	SELL	$59.34 - $66.74 $10.5 Million - $11.8 Million	-177,324 Reduced 16.06%	927,073 $58.5 Million
Q4 2020 Jan 25, 2021	SELL	$57.74 - $65.43 $5.42 Million - $6.14 Million	-93,829 Reduced 7.83%	1,104,397 $68.5 Million
Q3 2020 Dec 14, 2020	SELL	$57.43 - $63.64 $3.56 Million - $3.95 Million	-62,069 Reduced 4.92%	1,198,226 $72.2 Million
Q2 2020 Jul 23, 2020	SELL	$54.82 - $64.09 $3.16 Million - $3.7 Million	-57,675 Reduced 4.38%	1,260,295 $74.1 Million
Q1 2020 Apr 23, 2020	SELL	$46.4 - $67.43 $1.96 Million - $2.85 Million	-42,251 Reduced 3.11%	1,317,970 $73.5 Million
Q4 2019 Jan 24, 2020	BUY	$49.21 - $64.19 $18.1 Million - $23.6 Million	367,525 Added 37.02%	1,360,221 $87.3 Million
Q3 2019 Oct 21, 2019	SELL	$42.77 - $50.71 $150,464 - $178,397	-3,518 Reduced 0.35%	992,696 $50.3 Million
Q2 2019 Jul 25, 2019	BUY	$44.62 - $49.34 $207,661 - $229,628	4,654 Added 0.47%	996,214 $45.2 Million
Q1 2019 Apr 19, 2019	BUY	$45.12 - $53.8 $534,175 - $636,938	11,839 Added 1.21%	991,560 $47.3 Million
Q4 2018 Jan 23, 2019	BUY	$48.76 - $63.23 $330,153 - $428,130	6,771 Added 0.7%	979,721 $50.9 Million
Q3 2018 Oct 19, 2018	SELL	$55.19 - $62.25 $4.2 Million - $4.74 Million	-76,113 Reduced 7.26%	972,950 $60.4 Million
Q2 2018 Aug 06, 2018	SELL	$50.53 - $62.98 $17.3 Million - $21.6 Million	-343,243 Reduced 24.65%	1,049,063 $58.1 Million
Q1 2018 Apr 20, 2018	SELL	$59.92 - $68.98 $2.35 Million - $2.7 Million	-39,214 Reduced 2.74%	1,392,306 $88.1 Million
Q4 2017 Jan 23, 2018	SELL	$59.94 - $65.35 $5.9 Million - $6.44 Million	-98,504 Reduced 6.44%	1,431,520 $87.7 Million
Q3 2017 Oct 23, 2017	BUY	$55.23 - $63.74 $84.5 Million - $97.5 Million	1,530,024	1,530,024 $97.5 Million

Others Institutions Holding BMY

# of Institutions

2,402

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $110B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account